Markets:

Overview

News

Currencies

International

Treasuries

Alector, Inc. - Common Stock (NQ:ALEC)

1.140 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 3, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Alector, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Nasdaq Jumps Over 200 Points, Crude Oil Rises Sharply ↗

September 09, 2022

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Friday.

Via Benzinga

Enphase Energy, Immunocore And Some Other Big Stocks Moving Lower On Friday ↗

September 09, 2022

U.S. stocks traded higher, with the Dow Jones gaining around 300 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

AbbVie Dumps An Early-Alzheimer's Candidate Developing In Collaboration With Alector ↗

July 08, 2022

Via Benzinga

Expert Ratings for Alector ↗

July 07, 2022

Within the last quarter, Alector (NASDAQ:ALEC) has observed the following analyst ratings:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022 ↗

April 13, 2022

Upgrades

Via Benzinga

Alector: Q4 Earnings Insights ↗

February 25, 2022

Alector (NASDAQ:ALEC) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022 ↗

September 09, 2022

Upgrades

Via Benzinga

R&D Efforts for Alzheimer’s Therapies on the Rise with over 120 Drugs in Development

March 31, 2022

Palm Beach, FL – March 31, 2022 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is an irreversible, progressive neurodegenerative disease. It is the most common cause of dementia...

Via FinancialNewsMedia

Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022 ↗

July 07, 2022

Upgrades

Via Benzinga

Alector Highlights Mid-Stage Study Data On Lead Dementia Drug ↗

March 15, 2022

Alector Inc (NASDAQ: ALEC) is flashing some AL001 (latozinemab) Phase 2 data at an Alzheimer’s and Parkinson’s disease conference, this time in dementia with a different type of mutation: C9orf72.

Via Benzinga

The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings ↗

March 13, 2022

Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments...

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Rises 100 Points; Gold Surges 2.5% ↗

March 08, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq adding 100 points on Tuesday. The Dow traded up 0.39% to 32,946.58 while the NASDAQ rose 0.78% to 12,931.15....

Via Benzinga

88 Biggest Movers From Yesterday ↗

March 09, 2022

Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) climbed 203.3% to settle at $1.00 on Tuesday. Hycroft recently reported preliminary FY21 operating results. Kala...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 08, 2022

Gainers Kala Pharmaceuticals (NASDAQ:KALA) stock rose 86.8% to $1.14 during Tuesday's regular session. The current volume of 2.6 million shares is 326.2% of Kala...

Via Benzinga

Mid-Day Market Update: U.S. Stocks Turn Higher; Dow Jumps Over 400 Points ↗

March 08, 2022

U.S. stocks turned higher midway through trading, with the Dow Jones climbing more than 400 points on Tuesday. The Dow traded up 1.28% to 33,236.65 while the NASDAQ rose 1.61% to...

Via Benzinga

5 Stocks Insiders Are Selling ↗

November 11, 2021

When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 30, 2021

Gainers FibroGen (NASDAQ:FGEN) stock mov...

Via Benzinga

60 Stocks Moving In Tuesday's Mid-Day Session ↗

March 08, 2022

Gainers Enservco Corporation (NYSE: ENSV) surged 228% to $8.20 after jumping around 85% on Monday. Hycroft Mining Holding Corporation (NASDAQ: HYMC) rose 168% to $0.8850. Hycroft...

Via Benzinga

Chief Executive Officer Of Alector Sold $2.77 Million In Stock ↗

September 24, 2021

Arnon Rosenthal, Chief Executive Officer at Alector (NASDAQ:ALEC), made a large insider sell on September 23, according to a new SEC filing. What Happened: A Form 4 filing from...

Via Benzinga

Topics Regulatory Compliance

Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022 ↗

March 08, 2022

Upgrades According to Janney Montgomery Scott, the prior rating for Wintrust Financial Corp (NASDAQ:WTFC) was changed from Neutral to Buy. Wintrust Finl earned $1.58 in the fourth...

Via Benzinga

Why Alector Shares Are Diving Today ↗

September 08, 2021

There has been a major shakeup in the C-suite.

Via The Motley Fool

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗

November 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...

Via Benzinga

Mid-Afternoon Market Update: Kadmon Surges Following Acquisition News; UiPath Shares Drop ↗

September 08, 2021

Toward the end of trading Wednesday, the Dow traded down 0.24% to 35,015.62 while the NASDAQ fell 0.61% to 15,280.10. The S&P also fell, dropping 0.20% to 4,510.78. The U.S....

Via Benzinga

Topics Stocks

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗

November 08, 2021

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 08, 2021

Gainers Kadmon Holdings (NASDAQ:KDMN) shares increased by 72.64% to $9.15 during Wednesday's regular session. Trading volume for Kadmon Holdings's stock is 95.3...

Via Benzinga

54 Biggest Movers From Yesterday ↗

September 09, 2021

Gainers eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) shares jumped 111.8% to settle at $27.17 on Wednesday after jumping 50% on Tuesday. Helbiz, Inc. (NASDAQ: HLBZ) gained 84% to...

Via Benzinga

Mid-Day Market Update: Crude Oil Rises 1%; REV Group Shares Plummet ↗

September 08, 2021

Midway through trading Wednesday, the Dow traded down 0.45% to 34,942.88 while the NASDAQ fell 1.09% to 15,207.45. The S&P also fell, dropping 0.55% to 4,495.35. The U.S. has...

Via Benzinga

Topics Stocks

30 Stocks Moving In Wednesday's Mid-Day Session ↗

September 08, 2021

Gainers Kadmon Holdings, Inc. (NASDAQ: KDMN) shares jumped 72.6% to $9.15. Sanofi announced Wednesday it has agreed to acquire New York-based biopharma Kadmon in a $1.9 billion...

Via Benzinga

Mid-Morning Market Update: Markets Mixed; Korn Ferry Reports Upbeat Q1 Results ↗

September 08, 2021

Following the market opening Wednesday, the Dow traded up 0.03% to 35,111.48 while the NASDAQ fell 0.27% to 15,332.05. The S&P also fell, dropping 0.02% to 4,519.29. The U.S....

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod ↗

September 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.